Literaturliste Chirurgen Magazin + BAO Depesche 4.2020 (November 2020)

Hier finden Sie die Literaturlisten der Fachbeiträge aus der aktuellen Ausgabe.

Literaturliste zum Beitrag „Die Vakuumversiegelung (V.A.C.) von Wunden im EBM von Dr. Walter Wetzel-Roth (Chirurgen Magazin + BAO Depesche 4.2020, November 2020, Seite 34 f.

1. Seidel D, Storck M, Lawall H, Wozniak G, Mauckner P, Hochlehnert D, Wetzel-Roth W, Sondern K, Hahn M, Ro- thenaicher G, Krönert T, Zink K, Neugebauer E: Negative pressure wound therapy compared with standard moist wound care on diabetic foot ulcers in real-life cli- nical practice: results of the German Dia-Fu-RCT BMJ Open 2020;10: e026345. doi: 10.1136/bmjopen- 2018-026345. 
2. Seidel D, Diedrich S, Herrle F,Thiele- mann F, Marusch F, Schirren R, Talau- licar R, Gehrig T, Lehwald-Tywuschick N, Glanemann M, Bunse J Hüttemann M, Braumann C, Heizmann O, Miese- rer M, Krönert T, Gretschel S, Lefering R: Negative Pressure Wound Therapy vs Conventional Wound Treatment in Sub- cutaneous Abdominal Wound Healing Impairment – The SAWHI Randomized Clinical Trial. JAMA Surg. 2020; 155(6): 469–478. doi:10.1001/jamasurg.2020. 0414 April 15, 2020. 

Literaturliste zum Beitrag „S2-Leitlinie zur Indikation Knieendoprothese“ von Edith Leisten (Chirurgen Magazin + BAO Depesche 4.2020, November 2020, Seite 42 f.)

1.        Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323–30.

2.        Moskowitz RW. The burden of osteoarthritis: clinical and quality-of-life issues. Am J Manag Care 2009;15:S223-9.

3.        Palazzo C, Nguyen C, Lefevre-Colau M-M, Rannou F, Poiraudeau S. Risk factors and burden of osteoarthritis. Ann Phys Rehabil Med 2016;59:134–8.

4.        Daigle ME, Weinstein AM, Katz JN, Losina E. The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. Best Pract Res Clin Rheumatol 2012;26:649–58.

5.        Waimann CA, Fernandez-Mazarambroz RJ, Cantor SB, et al. Cost-effectiveness of total knee replacement: a prospective cohort study. Arthritis Care Res (Hoboken) 2014;66:592–9.

6.        Carr AJ, Robertsson O, Graves S, et al. Knee replacement. The Lancet 2012;379:1331–40.

7.        Scott CEH, Howie CR, MacDonald D, Biant LC. Predicting dissatisfaction following total knee replacement: a prospective study of 1217 patients. J Bone Joint Surg Br 2010;92:1253–8.

8.        Dunbar MJ, Richardson G, Robertsson O. I can’t get no satisfaction after my total knee replacement: rhymes and reasons. Bone Joint J 2013;95-B:148–52.

9.        Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KDJ. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res 2010;468:57–63.

10.     Dowsey MM, Spelman T, Choong PFM. Development of a Prognostic Nomogram for Predicting the Probability of Nonresponse to Total Knee Arthroplasty 1 Year After Surgery. J Arthroplasty 2016;31:1654–60.

11.     Noble PC, Conditt MA, Cook KF, Mathis KB. The John Insall Award: Patient expectations affect satisfaction with total knee arthroplasty. Clin Orthop Relat Res 2006;452:35–43.

12.     Gademan MGJ, Hofstede SN, Vliet Vlieland TPM, Nelissen RGHH, Marang-van de Mheen PJ. Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview. BMC Musculoskelet Disord 2016;17:463.

13.     Cobos R, Latorre A, Aizpuru F, et al. Variability of indication criteria in knee and hip replacement: an observational study. BMC Musculoskelet Disord 2010;11:249.

Literaturliste zum Beitrag „Aktuelle konservative und operative Therapie in der Lymphologie“ von Dr. Stefan Mann, Priv.-Doz. Dr. Christian D. Taeger, Markus Artner, Reinhard Rieger, Heinz Rohn (Chirurgen Magazin + BAO Depesche 4.2020, November 2020, Seite 44 ff.)

1. Jung A, Behrens S, Schmidt ME, Thoene K, Obi N, Hüsing A, Benner A, Steindorf K, Chang-Claude J (2019): Pre- to postdiagnosis physical activity and prognosis in postmenopausal breast cancer survivors. Breast Cancer Res 21, 117 (2019). https://doi.org/10.1186/s13058-019-1206-0 Vorabmitteilung Deutsches Ärzteblatt 12.11.2019
2. Bower JE. Cancer-related fatigue– mechanisms, risk factors, and treat- ments. Nature reviews. Clinical oncology 2014; 11: 597–609
3. Gerritsen JKW, Vincent AJPE. Exercise improves quality of life in patients with cancer. A systematic review and meta-analysis of randomised con- trolled trials. British journal of sports medicine 2016; 50: 796–803
4. Siegmund-Schultze, Nicola Onkologie: Sport ist so wichtig wie ein Krebsmedikament Dtsch Arztebl 2009; 106(10): A-444 / B-382 / C-370
5. Baumann F, Schüle K, Fauser A, Kraut I: Auswirkungen von Bewegungstherapie bei und nach Knochenmark-/Stammzelltransplantation; Deutsche Zeitschrift für Onkologie 2005; 37: 152–8.
6. Thune I, Brenn T, Lund E, Gaard M: Physical Activity and the Risk of Breast Cancer; NEJM 1997, 336: 1269–75
7. Friedenreich CM, Neilson HK, Farris MS et al. Physical Activity and Cancer Outcomes. A Precision Medicine Approach. Clinical cancer research : an official journal of the American Asso- ciation for Cancer Research 2016; 22: 4766–4775
8. JH Dayan, JM Ayala, I Koshima Lymphedema: Microsurgical Reconstruction in Kapitel (S 40 – 60) in Wei F-C, Mardini S. Flaps and reconstructive surgery. 2nd edition. ed. Edinburgh ; New York: Elsevier, 2017

Literaturliste zum Beitrag „Rationale Thrombophilie-Diagnostik im Einklang mit den Leitlinien“ Von Dr. Jochen Peter, Dr. Siamak Pourhassan, Priv.-Doz. Dr. Rainer Zotz, Prof. Dr. Günther Giers (Chirurgen Magazin + BAO Depesche 4.2020, November 2020, Seite 48 ff.)

1. S2-Leitlinie: Diagnostik und Therapie der Venenthrombose und der Lungenembolie. http://www.awmf.org. Zugegriffen 09.09.2020
2. S2-Leitlinie Diagnostik und Therapie der Venenthrombose und der Lungenembolie. AWMF-Leitlinien. 2015 http://www.awmf.org. Zugegriffen 09.09.2020
3. Kroeger K, Pleye J, Pourhassan S, Peter J, Noppeney T. Empfehlungen zur Anwendung der indirekten und direkten Antikoagulanzien zur langfristigen Sekundärprophylaxe nach venösen Thromboembolien. Zentralbl Chir 2018; 143(05): 526-532
4. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. NEJM 1995: 332: 1661-1665.
5. Kearon C, Akl EA. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 2014; 123: 1794-1801.